<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AE7EA01F-0FBC-454A-9BBC-762E455AC90B"><gtr:id>AE7EA01F-0FBC-454A-9BBC-762E455AC90B</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Emrys</gtr:otherNames><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9CF66BB9-2F2B-4509-BDDD-9A236AE94E4C"><gtr:id>9CF66BB9-2F2B-4509-BDDD-9A236AE94E4C</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Simpson</gtr:surname><gtr:orcidId>0000-0003-4731-7294</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C42B6BEC-7792-47AD-B3C3-E6E5E9F3C208"><gtr:id>C42B6BEC-7792-47AD-B3C3-E6E5E9F3C208</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Wedge</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15030"><gtr:id>DDE821EA-BB05-4340-8DE7-F3C3B8F17184</gtr:id><gtr:title>Newcastle Confidence in Concept 2015</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15030</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The Confidence in Concept scheme is a key part of MRC?s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach ?? before seeking more substantive funding.&amp;nbsp; It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>750000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>313973</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Examining efficacy of a novel bromodomain inhibitor AZD5153 in castrate resistant prostate cancer (MRC)</gtr:description><gtr:end>2020-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/P009972/1</gtr:fundingRef><gtr:id>285110E5-D5CB-4088-88B4-7A2426C360FE</gtr:id><gtr:outcomeId>58c800ae9c88c5.41340275</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The aim of the project is to ready our breath-acetone device prototype for use in human subjects and to collect performance data so that we will be in a position to apply for external funding to conduct a series of clinical investigations designed to establish the potential role of the device in a range of clinical settings. Such positioning requires that the performance of the device be optimised and its accuracy be validated by comparing measurements with the gold-standard measuring technique, gas chromatography. Once the accuracy of the device has been confirmed we will install online breath-sampling capability for passive acetone-concentration measurements on humans in real time.</gtr:description><gtr:grantRef>MC_PC_15030</gtr:grantRef><gtr:id>26B3CFD6-DBC4-4611-9E47-4A28D9FB72C9</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c97181da2909.59993300</gtr:outcomeId><gtr:patentId>PCT/EP2016/068471</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Gas-Phase Fluorescence Analysis</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3E3EBE9D-3A07-4620-98FD-3532E55FCE67</gtr:id><gtr:title>How to build a human.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1f9ae12417e7085ab2d1c329a907993"><gtr:id>b1f9ae12417e7085ab2d1c329a907993</gtr:id><gtr:otherNames>Mellough CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>58c7cf4e697f20.90064802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A47A6F5-39E0-4BAB-9D8A-D3457784EF77</gtr:id><gtr:title>Thermal stability, storage and release of proteins with tailored fit in silica.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25c04fa16b3963d8d32fe758dc53ce3a"><gtr:id>25c04fa16b3963d8d32fe758dc53ce3a</gtr:id><gtr:otherNames>Chen YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa800d0376967.14672681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D9FFEC4-6F71-4C1D-A008-AF12C37AE6FB</gtr:id><gtr:title>Using Zinc Finger Nuclease Technology to Generate CRX-Reporter Human Embryonic Stem Cells as a Tool to Identify and Study the Emergence of Photoreceptors Precursors During Pluripotent Stem Cell Differentiation.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52f57e90923c8c783ce1b858d944c58e"><gtr:id>52f57e90923c8c783ce1b858d944c58e</gtr:id><gtr:otherNames>Collin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>5aa800cf4e4158.66399561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D026649-48F1-44FC-8969-4DA4EE4BB0BC</gtr:id><gtr:title>3D culture of human pluripotent stem cells in RGD-alginate hydrogel improves retinal tissue development.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/681fd0801fd1de7e49ac0cff1382adbc"><gtr:id>681fd0801fd1de7e49ac0cff1382adbc</gtr:id><gtr:otherNames>Hunt NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>58c7d02145af21.87397611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C74D20A5-4865-48CC-8A19-019CBB2A2D4F</gtr:id><gtr:title>Tissue engineering using pluripotent stem cells: multidisciplinary approaches to accelerate bench-to-bedside transition.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/681fd0801fd1de7e49ac0cff1382adbc"><gtr:id>681fd0801fd1de7e49ac0cff1382adbc</gtr:id><gtr:otherNames>Hunt NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>58c7cf6b868b82.53445209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19CE7BBB-2975-41F5-B943-B9D5FD03E6FA</gtr:id><gtr:title>GOF-STAT1 mutations mediate enhanced effects of type 1 interferons</gtr:title><gtr:parentPublicationTitle>Clin Imm 2016</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d15b3c5e0b55786e1eb593c4103ce667"><gtr:id>d15b3c5e0b55786e1eb593c4103ce667</gtr:id><gtr:otherNames>Chan CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c7ce2d0cd502.47160908</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15030</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>